Alnylam Pharmaceuticals
ALNY
#586
Rank
NZ$60.45 B
Marketcap
$468.73
Share price
0.32%
Change (1 day)
55.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company